Literature DB >> 20661225

Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy.

Guoqiang Zhang1, Alison L Thomas, Amanda L Marshall, Kelly A Kernan, Yanyuan Su, Yi Zheng, Jiro Takano, Takaomi C Saido, Allison A Eddy.   

Abstract

The nicotinic acetylcholine receptor α1 (nAChRα1) was investigated as a potential proinflammatory molecule in the kidney, given a recent report that it is an alternative urokinase plasminogen activator (uPA) receptor, in addition to the classical receptor uPAR. Two animal models and in vitro monocyte studies were involved: (1) In an ApoE(-/-) mouse model of chronic kidney disease, glomerular-resident cells and monocytes/macrophages were identified as the primary cell types that express nAChRα1 during hypercholesterolemia/uninephrectomy-induced nephropathy. Silencing of the nAChRα1 gene for 4 months (6 months on Western diet) prevented the increases in renal monocyte chemoattractant protein-1 and osteopontin expression levels and F4/80+ macrophage infiltration compared with the nonsilenced mice. These changes were associated with significantly reduced transforming growth factor-β1 mRNA (50% decrease) and α smooth muscle actin-positive (αSMA+) myofibroblasts (90% decrease), better glomerular and tubular basement membranes (GBM/TBM) preservation (threefold less disintegration), and better renal function preservation (serum creatinine 40% lower) in the nAChRα1-silenced mice. The nAChRα1 silencing was also associated with significantly reduced renal tissue calcium deposition (78% decrease) and calpain-1 (but not calpain-2) activation (70% decrease). (2) The nAChRα1 was expressed in vitro by mouse monocyte cell line WEHI-274.1. The silencing of nAChRα1 significantly reduced both calpain-1 and -2 activities, and reduced the degradation of the calpain substrate talin. (3) To further explore the role of calpain-1 activity in hypercholesterolemic nephropathy, disease severities were compared in CAST(-/-)ApoE(-/-) (calpain overactive) mice and ApoE(-/-) mice fed with Western diet for 10 months (n=12). Macrophages were the main cell type of renal calpain-1 production in the model. The number of renal F4/80+ macrophages was 10-fold higher in the CAST(-/-)ApoE(-/-) mice (P<0.05), and was associated with a significantly higher level of αSMA+ cells, increased GBM/TBM destruction, and higher serum creatinine levels. Our studies suggest that the receptor nAChRα1 is an important regulator of calpain-1 activation and inflammation in the chronic hypercholesterolemic nephropathy. This new proinflammatory pathway may also be relevant to other disorders beyond hyperlipidemic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661225      PMCID: PMC3188436          DOI: 10.1038/labinvest.2010.135

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  50 in total

1.  A role for pericytes as microenvironmental regulators of human skin tissue regeneration.

Authors:  Sophie Paquet-Fifield; Holger Schlüter; Amy Li; Tara Aitken; Pradnya Gangatirkar; Daniel Blashki; Rachel Koelmeyer; Normand Pouliot; Manuela Palatsides; Sarah Ellis; Nathalie Brouard; Andrew Zannettino; Nick Saunders; Natalie Thompson; Jason Li; Pritinder Kaur
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

2.  Calpains mediate calcium and chloride influx during the late phase of cell injury.

Authors:  S L Waters; S S Sarang; K K Wang; R G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

Review 3.  Endothelial nicotinic acetylcholine receptors and angiogenesis.

Authors:  John P Cooke; Yohannes T Ghebremariam
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

4.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.

Authors:  Benjamin D Humphreys; Shuei-Liong Lin; Akio Kobayashi; Thomas E Hudson; Brian T Nowlin; Joseph V Bonventre; M Todd Valerius; Andrew P McMahon; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

5.  Metabolic acidosis inhibits soft tissue calcification in uremic rats.

Authors:  F J Mendoza; I Lopez; A Montes de Oca; J Perez; M Rodriguez; E Aguilera-Tejero
Journal:  Kidney Int       Date:  2007-11-07       Impact factor: 10.612

6.  A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis.

Authors:  Guoqiang Zhang; Kelly A Kernan; Alison Thomas; Sarah Collins; Yumei Song; Ling Li; Weizhong Zhu; Renee C Leboeuf; Allison A Eddy
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

7.  Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury.

Authors:  Michael M Yeboah; Xiangying Xue; Mohammad Javdan; Myron Susin; Christine N Metz
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09

Review 8.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 10.  Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.

Authors:  Ihab M Wahba; Robert H Mak
Journal:  Clin J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 8.237

View more
  6 in total

1.  Selenoprotein K is a novel target of m-calpain, and cleavage is regulated by Toll-like receptor-induced calpastatin in macrophages.

Authors:  Zhi Huang; Fukun W Hoffmann; Robert L Norton; Ann C Hashimoto; Peter R Hoffmann
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

2.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

3.  Calpain 2 activity increases at the time of implantation in rat uterine luminal epithelial cells and administration of calpain inhibitor significantly reduces implantation sites.

Authors:  Yui Kaneko; Christopher R Murphy; Margot L Day
Journal:  Histochem Cell Biol       Date:  2013-11-23       Impact factor: 4.304

4.  Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis.

Authors:  Minghui Li; Yangang Su; Yong Yu; Ying Yu; Xinggang Wang; Yunzeng Zou; Junbo Ge; Ruizhen Chen
Journal:  Int J Cardiol       Date:  2016-07-09       Impact factor: 4.164

Review 5.  Myorelaxants in ARDS patients.

Authors:  Sami Hraiech; Takeshi Yoshida; Djillali Annane; Abhijit Duggal; Vito Fanelli; Arnaud Gacouin; Leo Heunks; Samir Jaber; Peter D Sottile; Laurent Papazian
Journal:  Intensive Care Med       Date:  2020-11-07       Impact factor: 17.440

6.  Identification of Hub Genes Associated with COPD Through Integrated Bioinformatics Analysis.

Authors:  Lin Chen; Donglan Zhu; Jinfu Huang; Hui Zhang; Guang Zhou; Xiaoning Zhong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.